Mette Kruse Klausen
5PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 09, 2025
Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double-blinded, placebo-controlled clinical trial.Malthe E B Hviid, Lea A N Christoffersen, Mette K Klausen
|Feb 01, 2025
Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder.Mette Kruse Klausen, Gitte Moos Knudsen, Tina Vilsbøll
|Jan 08, 2025
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial).Mette Kruse Klausen, Tugba Kuzey, Julie Niemann Pedersen
|Nov 24, 2023
GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders.Lorenzo Leggio, Christian S Hendershot, Mehdi Farokhnia
|Sep 17, 2021
The role of glucagon-like peptide 1 (GLP-1) in addictive disorders.Mette Kruse Klausen, Morgane Thomsen, Gitta Wortwein
Pageof 1
Frequent Collaborators
4 joint publications
Anders Fink-Jensen
3 joint publications
Tina Vilsbøll
1 joint publications
Lea A N Christoffersen
1 joint publications
Thorsten Brodersen
1 joint publications
Ole B Pedersen
1 joint publications
Sisse R Ostrowski
1 joint publications
Mathias E Jensen
1 joint publications
Morgane Thomsen
1 joint publications
Gitta Wortwein
1 joint publications
Lorenzo Leggio
